NIH launches clinical trial of Epstein-Barr virus vaccine
National Institutes of Health (NIH) sent this bulletin at 05/06/2022 10:30 AM EDTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
05/06/2022 10:00 AM EDT
EBV is the primary cause of infectious mononucleosis and is associated with certain cancers and autoimmune diseases.
|
Update Your E-mail Address | Add Subscriptions | Unsubscribe All If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health.
|
